Health
Novavax Inks Vaccine Deals In Japan, India; Analyst Sees 70% Stock Upside – Gooruf
As part of the partnership, Novavax ( NVAX ) will license COVID-19 vaccine technology to Takeda for local production and commercialization in Japan. In exchange, Novavax will receive payments based on the achievement of certain development and commercial mile…
Article summary
As part of the partnership, Novavax ( NVAX ) will license COVID-19 vaccine technology to Takeda for local production and commercialization in Japan. In exchange, Novavax will receive payments based on the achievement of certain development and commercial milestones, as well as a portion of vaccine proceeds….
-
Noosa News18 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General18 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
General20 hours agoPerth man charged after investigation into organised crime and tobacco store attacks
-
General10 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging